ENSG00000138363 Expression In 33 Tumors

Ensembl ID Gene symbol Log2 Foldchange Pvaue Cancer
ENSG00000138363 0.57 6.53e-12 HNSC
ENSG00000138363 0.86 2.51e-70 BRCA
ENSG00000138363 1.02 2.74e-41 COAD
ENSG00000138363 1.11 2.28e-17 READ
ENSG00000138363 0.98 1.56e-34 LUSC
ENSG00000138363 0.59 6.34e-11 LIHC
ENSG00000138363 0.76 9.56e-15 STAD
ENSG00000138363 0.89 1.17e-21 UCEC
ENSG00000138363 1.22 1.15e-60 LUAD
Ensembl ID Gene symbol Cancer types Pubmed ID
ENSG00000138363 tumors 10706887
ENSG00000138363 cancer 11323713
ENSG00000138363 urinary bladder inflammatory myofibroblastic tumor 12939746
ENSG00000138363 tumors 15998975
ENSG00000138363 tumors 18845790
ENSG00000138363 tumor 25823786
ENSG00000138363 inflammatory myofibroblastic tumor 27846861
ENSG00000138363 tumor 28267080
ENSG00000138363 cancer 29029884
ENSG00000138363 Tumor 29246230
ENSG00000138363 tumor 30099851
ENSG00000138363 cancers 30337562
ENSG00000138363 tumors 31139569
Ensembl ID Gene symbol Disease/phenotype Mutation type Mutated / Total samples Literature
ENSG00000138363 anaplastic large cell lymphoma gene_fusion 47.5% (19/40) 8 entries
ENSG00000138363 lung adenocarcinoma gene_fusion 4.545% (60/1320) 1 entry
ENSG00000138363 squamous cell lung carcinoma gene_fusion 2.659% (23/865) 1 entry
ENSG00000138363 large cell lung carcinoma gene_fusion 15.38% (4/26) 1 entry
ENSG00000138363 adenosquamous lung carcinoma gene_fusion 17.65% (3/17) 1 entry
ENSG00000138363 colorectal adenocarcinoma missense_variant 2.109% (24/1138) 2 entries
ENSG00000138363 Bladder Inflammatory Myofibroblastic Tumor gene_fusion 50.0% (1/2) 1 entry
ENSG00000138363 Liver Inflammatory Myofibroblastic Tumor gene_fusion 50.0% (1/2) 1 entry
ENSG00000138363 colon adenocarcinoma missense_variant 3.878% (28/722) 5 entries
ENSG00000138363 colon adenocarcinoma stop_gained 3.878% (28/722) 2 entries
ENSG00000138363 prostate carcinoma sequence_alteration 0.8264% (4/484) 1 entry
ENSG00000138363 bladder transitional cell carcinoma missense_variant 1.46% (2/137) 2 entries
ENSG00000138363 basal cell carcinoma missense_variant 5.172% (3/58) 1 entry
ENSG00000138363 colorectal adenocarcinoma frameshift_variant 2.109% (24/1138) 1 entry
ENSG00000138363 cecum adenocarcinoma missense_variant 4.8% (6/125) 1 entry
ENSG00000138363 melanoma missense_variant 2.97% (3/101) 1 entry
ENSG00000138363 B-cell neoplasm gene_fusion 9.091% (1/11) 1 entry
ENSG00000138363 ovarian serous adenocarcinoma missense_variant 0.2972% (2/673) 1 entry
ENSG00000138363 small cell lung carcinoma missense_variant 0.9288% (3/323) 2 entries
ENSG00000138363 breast carcinoma missense_variant 0.2835% (4/1411) 1 entry
ENSG00000138363 colorectal adenocarcinoma sequence_alteration 2.109% (24/1138) 1 entry
ENSG00000138363 lung adenocarcinoma missense_variant 4.545% (60/1320) 4 entries
ENSG00000138363 esophageal squamous cell carcinoma missense_variant 0.8889% (6/675) 2 entries
ENSG00000138363 colorectal adenocarcinoma stop_gained 2.109% (24/1138) 2 entries
ENSG00000138363 colon adenocarcinoma sequence_alteration 3.878% (28/722) 2 entries
ENSG00000138363 cecum adenocarcinoma sequence_alteration 4.8% (6/125) 1 entry
ENSG00000138363 HER2 Positive Breast Carcinoma missense_variant 3.797% (6/158) 2 entries
ENSG00000138363 esophageal squamous cell carcinoma frameshift_variant 0.8889% (6/675) 1 entry
ENSG00000138363 head and neck squamous cell carcinoma missense_variant 0.134% (1/746) 1 entry
ENSG00000138363 small cell lung carcinoma sequence_alteration 0.9288% (3/323) 1 entry
ENSG00000138363 melanoma frameshift_variant 2.97% (3/101) 1 entry
ENSG00000138363 diffuse gastric adenocarcinoma sequence_alteration 1.266% (1/79) 1 entry
ENSG00000138363 clear cell renal carcinoma frameshift_variant 0.1451% (2/1378) 1 entry
ENSG00000138363 Brain Stem Glioblastoma sequence_alteration 1.786% (1/56) 1 entry
ENSG00000138363 colon carcinoma stop_gained 12.5% (1/8) 1 entry
ENSG00000138363 bile duct adenocarcinoma missense_variant 0.5291% (1/189) 1 entry
ENSG00000138363 acute myeloid leukemia sequence_alteration 0.1103% (1/907) 1 entry
ENSG00000138363 Ampulla of Vater Carcinoma sequence_alteration 1.176% (1/85) 1 entry
ENSG00000138363 rectal adenocarcinoma missense_variant 0.4525% (1/221) 1 entry
ENSG00000138363 diffuse large B-cell lymphoma missense_variant 0.6579% (2/304) 1 entry
ENSG00000138363 colon adenocarcinoma frameshift_variant 3.878% (28/722) 1 entry
ENSG00000138363 oral squamous cell carcinoma missense_variant 0.4878% (1/205) 1 entry
ENSG00000138363 breast ductal adenocarcinoma frameshift_variant 2.397% (14/584) 1 entry
ENSG00000138363 rectal adenocarcinoma frameshift_variant 0.4525% (1/221) 1 entry
ENSG00000138363 gastric intestinal type adenocarcinoma missense_variant 1.176% (1/85) 1 entry
ENSG00000138363 Merkel cell skin cancer sequence_alteration 3.333% (1/30) 1 entry
ENSG00000138363 cecum adenocarcinoma frameshift_variant 4.8% (6/125) 1 entry
Ensembl ID Gene symbol Cancer P-value Which worse show
ENSG00000138363 SARC 0.034 low
ENSG00000138363 PAAD 0.004 high
ENSG00000138363 UCEC 0.032 high
ENSG00000138363 THCA 0.00059 low
ENSG00000138363 HNSC 0.035 high
ENSG00000138363 READ 0.023 low
ENSG00000138363 LUAD 0.0017 high
ENSG00000138363 PCPG 0.00023 high
ENSG00000138363 BRCA 0.022 high
ENSG00000138363 KIRC 0.0099 high
ENSG00000138363 BLCA 0.0019 high
ENSG00000138363 LAML 0.0025 high
Ensembl ID Gene symbol Cancer CNV type -log10(q-value) G-score average amplitude frequency
ENSG00000138363 LUSC Del 16.852113 0.192759 0.409312 0.291417
ENSG00000138363 CESC Del 31.945263 0.333236 0.536632 0.386441
ENSG00000138363 KIRP Amp 1.259300 0.069152 0.554374 0.163194
ENSG00000138363 KIRP Del 1.155269 0.031577 0.592318 0.034722
ENSG00000138363 SARC Del 2.679215 0.172297 0.464932 0.342412
ENSG00000138363 ESCA Del 1.197188 0.111207 0.356179 0.233696
ENSG00000138363 HNSC Del 20.718035 0.175257 0.388465 0.275862
ENSG00000138363 BLCA Del 22.825597 0.267213 0.438184 0.455882
ENSG00000138363 KIRC Del 8.972097 0.062950 0.536222 0.083333